查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790479

個人化醫療市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場預測，2025 年至 2033 年

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

個人化醫療市場概況

2024年全球個人化醫療市場規模估計為5,671億美元，預計2033年將達到1,1961.8億美元，2025年至2033年的複合年成長率為8.80%。對標靶治療和精準診斷的需求不斷成長，大大推動了個人化醫療市場的擴張。

基因組技術、生物標記識別和數據驅動治療策略的進步使醫療保健提供者能夠根據患者的個別情況量身定做治療方案。這種方法可以提高治療效果，最大限度地減少副作用，並支持高效利用醫療資源。隨著全球慢性病和複雜疾病的增多，對個人化解決方案的關注度持續上升，推動了診斷、治療和健康數據整合平台的創新和投資。癌症、糖尿病和心血管疾病等慢性病的發生率上升，促使醫療保健提供者實施個人化治療策略。

個人化診斷提高了疾病識別的準確性，從而實現早期療育並改善臨床療效。 2024年，Illumina公司獲得FDA核准的TruSight Oncology綜合檢測分析了500多個基因，用於指南癌症的標靶治療。患者對遺傳易感性的認知不斷提高，這推動了基於DNA的檢測服務的廣泛應用。這種積極主動、針對患者的照護模式的趨勢，將繼續擴大醫療保健領域各個領域的市場潛力。

基因組學、人工智慧和數據分析領域的技術進步進一步推動了個人化醫療市場的成長。各公司正在利用次世代定序儀、生物標記發現和生物資訊學，開發針對個別患者特徵的創新解決方案。人工智慧與臨床決策的整合，使得快速分析複雜資料整合為可能，從而提高診斷準確性並豐富治療方法方案。遠端醫療平台和醫療IT系統促進了個人化醫療的遠距訪問，尤其是在慢性病管理方面。這些技術創新正在再形成醫療服務，並支持客製化方案的可擴展應用。

私部門投資和策略聯盟的不斷增加也促進了市場發展勢頭。製藥公司正在與診斷公司合作，共同開發用於標靶治療的伴隨診斷。新興企業和生物技術公司正憑藉創新的營養、健康和基因組學產品進入市場。消費者對健康最佳化和預防保健日益成長的興趣，推動了直接面對消費者的檢測和客製化健康計劃的需求。為了更好地參與市場競爭，各公司正專注於產品差異化、數據主導策略和全球擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章：個人化醫療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章：個人化醫療市場：產品業務分析

  • 2024年及2033年的產品市場佔有率
  • 產品細分儀表板
  • 市場規模、預測與趨勢分析（按產品，2021-2033 年）
  • 個性化醫療診斷
  • 個人化醫療
  • 個人化醫療
  • 個人化營養與健康

5.個人化醫療市場：最終用途業務分析

  • 2024年和2033年的最終用途市場佔有率
  • 最終用途細分儀表板
  • 按最終用途分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 醫院
  • 診斷中心
  • 研究和學術機構
  • 其他

第6章：個人化醫療市場：區域、估計與趨勢分析

  • 2024 年及 2033 年區域市場佔有率分析
  • 區域市場儀表板
  • 2021-2033年市場規模與預測趨勢分析
  • 北美洲
    • 按國家/地區，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • GE Healthcare
    • Illumina, Inc.
    • ASURAGEN, INC.
    • Abbott
    • Dako A/S
    • Exact Sciences Corporation
    • Danaher Corporation（Cepheid, Inc.）
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.
    • Precision Biologics
    • Celera Diagnostics LLC.
    • Biogen
    • Genelex
    • International Business Machines Corporation（IBM）
    • Genentech, Inc.
Product Code: 978-1-68038-443-7

Personalized Medicine Market Summary

The global personalized medicine market size was estimated at USD 567.10 billion in 2024 and is projected to reach USD 1,196.18 billion by 2033, growing at a CAGR of 8.80% from 2025 to 2033. The growing demand for targeted therapies and precision diagnostics is significantly driving the expansion of the personalized medicine market.

Advances in genomic technologies, biomarker identification, and data-driven treatment strategies enable healthcare providers to tailor therapies to individual patient profiles. This approach enhances treatment efficacy, minimizes adverse effects, and supports more efficient use of healthcare resources. As chronic and complex diseases rise globally, the focus on personalized solutions continues to strengthen, fostering innovation and investment across diagnostics, therapeutics, and health data integration platforms. The rise in chronic conditions such as cancer, diabetes, and cardiovascular diseases is prompting healthcare providers to implement individualized treatment strategies.

Personalized diagnostics deliver greater accuracy in disease identification, leading to earlier intervention and better clinical outcomes. Personalized diagnostics delivered greater accuracy in disease identification, as in 2024 when Illumina's FDA approved TruSight Oncology Comprehensive test analyzed over 500 genes to guide targeted cancer treatments. The increasing awareness among patients of genetic predispositions supports the uptake of DNA-based testing services. This movement toward proactive, patient-specific care models continues to expand the market's potential across medical domains.

Technological advancements in genomics, artificial intelligence, and data analytics further fuel growth in the personalized medicine market. Companies are leveraging next-generation sequencing, biomarker discovery, and bioinformatics to develop innovative solutions tailored to individual patient profiles. AI integration into clinical decision-making is enabling faster analysis of complex datasets, enhancing diagnostic precision and therapy selection. Telemedicine platforms and health IT systems facilitate remote access to personalized care, especially in chronic disease management. These technological innovations are reshaping healthcare delivery and supporting the scalable adoption of customized approaches.

Increasing private sector investments and strategic collaborations are also contributing to market momentum. Pharmaceutical companies are partnering with diagnostics firms to co-develop companion diagnostics for targeted therapies. Startups and biotech firms are entering the market with innovative nutrition, wellness, and genomics offerings. Expanding consumer interest in health optimization and preventive care is boosting demand for direct-to-consumer testing and customized wellness plans. Market players focus on product differentiation, data-driven strategies, and global expansion to strengthen their competitive positions.

Global Personalized Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global personalized medicine market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Personalized Medicine Diagnostics
    • Genetic Testing
    • Direct-To-Consumer (DTC) Diagnostics
    • Esoteric Lab Services
    • Esoteric Lab Tests
  • Personalized Medicine Therapeutics
    • Pharmaceutical
    • Genomic Medicine
    • Medical Devices
  • Personalized Medical Care
    • Telemedicine
    • Health Information Technology
  • Personalized Nutrition & Wellness
    • Retail Nutrition
    • Complementary & Alternative Medicine
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Personalized Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Personalized Medicine Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Personalized Medicine Diagnostics
    • 4.4.1. Personalized Medicine Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.4.2. Genetic Testing
      • 4.4.2.1. Genetic Testing Market, 2021 - 2033 (USD Million)
    • 4.4.3. Direct-To-Consumer (DTC) Diagnostics
      • 4.4.3.1. Direct-To-Consumer (DTC) Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.4.4. Esoteric Lab Services
      • 4.4.4.1. Esoteric Lab Services Market, 2021 - 2033 (USD Million)
    • 4.4.5. Esoteric Lab Tests
      • 4.4.5.1. Esoteric Lab Tests Market, 2021 - 2033 (USD Million)
  • 4.5. Personalized Medicine Therapeutics
    • 4.5.1. Personalized Medicine Therapeutics Market, 2021 - 2033 (USD Million)
    • 4.5.2. Pharmaceutical
      • 4.5.2.1. Pharmaceutical Market, 2021 - 2033 (USD Million)
    • 4.5.3. Genomic Medicine
      • 4.5.3.1. Genomic Medicine Market, 2021 - 2033 (USD Million)
    • 4.5.4. Medical Devices
      • 4.5.4.1. Medical Devices Market, 2021 - 2033 (USD Million)
  • 4.6. Personalized Medical Care
    • 4.6.1. Personalized Medical Care Market, 2021 - 2033 (USD Million)
    • 4.6.2. Telemedicine
      • 4.6.2.1. Telemedicine Market, 2021 - 2033 (USD Million)
    • 4.6.3. Health Information Technology
      • 4.6.3.1. Health Information Technology Market, 2021 - 2033 (USD Million)
  • 4.7. Personalized Nutrition & Wellness
    • 4.7.1. Personalized Nutrition & Wellness Market, 2021 - 2033 (USD Million)
    • 4.7.2. Retail Nutrition
      • 4.7.2.1. Retail Nutrition Market, 2021 - 2033 (USD Million)
    • 4.7.3. Complementary & Alternative Medicine
      • 4.7.3.1. Complementary & Alternative Medicine Market, 2021 - 2033 (USD Million)

Chapter 5. Personalized Medicine Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2033
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 5.5. Diagnostic Centers
    • 5.5.1. Diagnostic Centers Market, 2021 - 2033 (USD Million)
  • 5.6. Research & Academic Institutes
    • 5.6.1. Research & Academic Institutes Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Personalized Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Personalized Medicine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. End Use Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. End Use Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. End Use Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. End Use Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. End Use Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. End Use Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. End Use Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. End Use Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. End Use Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. End Use Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. End Use Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. End Use Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. End Use Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. End Use Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. End Use Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. End Use Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. End Use Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. End Use Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. End Use Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. End Use Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. End Use Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. End Use Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. End Use Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. GE Healthcare
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Illumina, Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. ASURAGEN, INC.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Abbott
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Dako A/S
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Exact Sciences Corporation
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Danaher Corporation (Cepheid, Inc.)
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Decode Genetics, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. QIAGEN
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Exagen Inc.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Precision Biologics
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Celera Diagnostics LLC.
      • 7.5.12.1. Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
    • 7.5.13. Biogen
      • 7.5.13.1. Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
    • 7.5.14. Genelex
      • 7.5.14.1. Overview
      • 7.5.14.2. Financial Performance
      • 7.5.14.3. Product Benchmarking
    • 7.5.15. International Business Machines Corporation (IBM)
      • 7.5.15.1. Overview
      • 7.5.15.2. Financial Performance
      • 7.5.15.3. Product Benchmarking
    • 7.5.16. Genentech, Inc.
      • 7.5.16.1. Overview
      • 7.5.16.2. Financial Performance
      • 7.5.16.3. Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Personalized medicine market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 9 U.S. Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 10 U.S. Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Canada Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 18 UK Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 19 UK Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Germany Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 21 Germany Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 22 France Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 23 France Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Italy Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 25 Italy Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Spain Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 27 Spain Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Norway Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 29 Norway Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Denmark Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 31 Denmark Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Sweden Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 33 Sweden Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Personalized medicine market, by product, 2021 - 2033 (USD
  • Table 36 Asia Pacific Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Japan Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 38 Japan Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 39 China Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 40 China Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 41 India Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 42 India Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Australia Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 44 Australia Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 45 South Korea Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 46 South Korea Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Thailand Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 48 Thailand Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Latin America Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 51 Latin America Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Brazil Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 53 Brazil Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Argentina Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 55 Argentina Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Personalized medicine market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 59 South Africa Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 60 South Africa Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 63 UAE Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 64 UAE Personalized medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Personalized medicine market, by product, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Personalized medicine market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Personalized medicine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Personalized medicine market dynamics
  • Fig. 12 Personalized medicine market: Porter's five forces analysis
  • Fig. 13 Personalized medicine market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Personalized medicine diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 16 Genetic testing market, 2021 - 2033 (USD Million)
  • Fig. 17 Direct-To-Consumer (DTC) Diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 18 Esoteric lab services market, 2021 - 2033 (USD Million)
  • Fig. 19 Esoteric lab tests market, 2021 - 2033 (USD Million)
  • Fig. 20 Personalized medicine therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 21 Pharmaceutical market, 2021 - 2033 (USD Million)
  • Fig. 22 Genomic medicine market, 2021 - 2033 (USD Million)
  • Fig. 23 Medical devices market, 2021 - 2033 (USD Million)
  • Fig. 24 Personalized medical care market, 2021 - 2033 (USD Million)
  • Fig. 25 Telemedicine market, 2021 - 2033 (USD Million)
  • Fig. 26 Health information technology market, 2021 - 2033 (USD Million)
  • Fig. 27 Personalized nutrition & wellness market, 2021 - 2033 (USD Million)
  • Fig. 28 Retail nutrition market, 2021 - 2033 (USD Million)
  • Fig. 29 Complementary & alternative medicine market, 2021 - 2033 (USD Million)
  • Fig. 30 End use market, 2021 - 2033 (USD Million)
  • Fig. 31 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 32 Diagnostic centers market, 2021 - 2033 (USD Million)
  • Fig. 33 Research & academic institutes market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Personalized medicine market revenue, by region
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. country dynamics
  • Fig. 39 U.S. Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 40 Canada country dynamics
  • Fig. 41 Canada Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico country dynamics
  • Fig. 43 Mexico Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 45 UK country dynamics
  • Fig. 46 UK Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany country dynamics
  • Fig. 48 Germany Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 49 France country dynamics
  • Fig. 50 France Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 51 Italy country dynamics
  • Fig. 52 Italy Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain country dynamics
  • Fig. 54 Spain Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden country dynamics
  • Fig. 58 Sweden Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark country dynamics
  • Fig. 60 Denmark Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan country dynamics
  • Fig. 63 Japan Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 64 China country dynamics
  • Fig. 65 China Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 66 India country dynamics
  • Fig. 67 India Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 68 Australia country dynamics
  • Fig. 69 Australia Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea country dynamics
  • Fig. 71 South Korea Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 72 Thailand country dynamics
  • Fig. 73 Thailand Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 75 Brazil country dynamics
  • Fig. 76 Brazil Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 77 Argentina country dynamics
  • Fig. 78 Argentina Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 79 MEA Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa country dynamics
  • Fig. 81 South Africa Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia country dynamics
  • Fig. 83 Saudi Arabia Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 84 UAE country dynamics
  • Fig. 85 UAE Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait country dynamics
  • Fig. 87 Kuwait Personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 88 Company categorization
  • Fig. 89 Company market position analysis
  • Fig. 90 Strategic framework